BIAFW BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM)
- 0.300
- -0.104-25.69%
Join BioAffinity Technologies' Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
10-Q：Q3 2024 四半期報告書
BioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
BioAffinity Technologies Announces Award of Japanese Patent for CyPath Lung
BioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
BioAffinity Technologies Announces Secondary Offering of 1.8M Shares
10-Q：Q2 2024 四半期報告書
10-Q：Q1 2024 四半期報告書
BioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 8-K：バイオアフィニティ・テクノロジーズ、2023年第4四半期および通年の決算を発表
BioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
BioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
Here's Why We're A Bit Worried About BioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation
BioAffinity Technologies News Update
Medical Director of Pennsylvania's Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins BioAffinity Technologies' Medical and Scientific Advisory Board and Incorporates CyPath Lung Into Medical Practice
BioAffinity Technologies Appoints Jamie Platt, Ph.D., to Its Board of Directors
CMS Posts Final Payment Determination for BioAffinity Technologies' CyPath Lung Effective January 2024
BIOAFFINITY TECHNOLOGIES INC C/WTS 12/08/2027 (TO PUR COM) | 8-K：BioAffinity Technologiesは2023年第3四半期の決算を発表し、ビジネスアップデートを提供します
BioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
BioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference